EDGAR GARCIA: Open Payments
NPI 1649677139 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,805 in 144 payments from 24 companies in 2025. Trend: 2023 $3,632 · 2024 $3,169 · 2025 $2,805
Food & beverage: $2,805
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $614 |
| ABBVIE INC. | 31 | $419 |
| AstraZeneca Pharmaceuticals LP | 5 | $366 |
| Amgen Inc. | 24 | $248 |
| Lilly USA, LLC | 6 | $221 |
| Phathom Pharmaceuticals, Inc. | 5 | $165 |
| Sumitomo Pharma America, Inc. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Boston Scientific Corporation | 3 | $70 |
| PFIZER INC. | 4 | $64 |
Products named: AIRSUPRA, Wegovy, Ozempic, VOQUEZNA, VRAYLAR, OTEZLA, ZEPBOUND, JARDIANCE.
Industry payments across TX — which companies pay providers there.
